Trial record 1 of 11 for:    HIBM
Previous Study | Return to List | Next Study

Phase I Clinical Trial of ManNAc in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM)

This study has been completed.
National Center for Advancing Translational Science (NCATS)
Therapeutics for Rare and Neglected Diseases (TRND)
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Human Genome Research Institute (NHGRI) ) Identifier:
First received: July 3, 2012
Last updated: April 3, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2013
  Estimated Primary Completion Date: No date given